HCW Biologics Stock Scheduled to Reverse Split on Friday, April 11th (NASDAQ:HCWB)

HCW Biologics Inc. (NASDAQ:HCWB)’s stock is going to reverse split on the morning of Friday, April 11th. The 1-40 reverse split was announced on Tuesday, April 1st. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 10th.

HCW Biologics Stock Up 0.3 %

HCWB opened at $0.28 on Thursday. The company has a market capitalization of $12.55 million, a PE ratio of -0.28 and a beta of 0.71. The firm has a 50-day simple moving average of $0.36 and a two-hundred day simple moving average of $0.44. HCW Biologics has a 52 week low of $0.21 and a 52 week high of $2.52.

HCW Biologics (NASDAQ:HCWB) last posted its earnings results on Friday, March 28th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $0.40 million during the quarter. HCW Biologics had a negative return on equity of 2,516.84% and a negative net margin of 1,067.82%.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.